UK fines Advanz £100m for raising thyroid drug price tenfold
pharmaphorum
JULY 29, 2021
Advanz hiked the price of a pack of liothyronine tablets – used to treat thyroid hormone deficiency – from £20 in 2009 to £248 in 2017, taking advantage of a lack of competition for the drug even though it was out of patent. ” Advanz itself was directly fined £40.9 million and £51.9 million, respectively. .”
Let's personalize your content